HRPP/ IRB Liaisons have the option to ‘Add HRPP Staff/ Members’ from the homepage and from the ‘+add user’ button on the ‘Find other users’ page. To prevent study team members (IREx Study Managers, PIs, and Coordinators) from being added as HRPP/IRB staff, IREx shows a pop-up asking whether the new user is HRPP / IRB personnel or study team. If study team, the user is directed to add the new user on the appropriate study.
Category Archives: FRL
Update Feature: All sites on a study are now listed in the +Grant Site Coordinator Access site dropdown menu
The ‘+Grant Site Coordinator Access’ button on the Participating Personnel dialog will now list all participating sites on the study. Previously, it only listed sites that have registered on the study.
However, the sIRB and Study Manager will not be allowed to add coordinators to sites that have NOT yet registered on the study. If a site that has not yet registered is selected, a pop-up will appear with the following text:
“This site has not yet registered on the study. Study team members cannot access the study until their site registers.”
Updated Feature: The ‘isCollectingLocalContext’ column is now included in the Participating Site export
The Participating Site Report now includes, ‘isCollectingLocalContext’ column to indicate whether local considerations are expected for the study. If not, you will not see or expect any dates for the HRP Survey or PI Survey being completed. A one (1) indicates the study is collecting local considerations.
Bug Fixes – November 7, 2022
Fixed: Do not allow sIRB to be added as a participating site on a study |
Fixed: Global Documents appear on the Approval History tab for study closures, which includes the IRB Documentation letter. |
Fixed: Site Amendment dialog no longer includes questions about the lead site’s enrollment status and the publish banner. |
Fixed: The current enrollment status of sites carries forward when the site’s approval is posted with the lead site. |
Fixed: The Study Manager’s site affiliation can be selected in IREx Setup. |
Fixed: Studies that are not capturing local considerations no longer send an email reminder to a relying site PI to complete the PI Survey . |
New Feature: Streamline Sharing and Notifying Relying Sites of new Continuing Review and Study-wide Amendment Approvals
Relying site approvals no longer have to be individually confirmed after publishing a continuing review or study-wide amendment. Now, if relying sites did not have site-specific changes, their approvals can be confirmed when adding the overall approval so that sites automatically get notified of the Continuing Review or Study-wide Amendment when the overall approval is published.
New Feature: Lead site consents will carry forward on Continuing Reviews if they did not change
Previously, IREx required new consent forms to be uploaded at the time of continuing review. However, when sIRBs do not re-stamp consents at the time of continuing review, a new consent is not approved and therefore a new version should not be uploaded. Now, sIRBs and Study Managers can indicate that the consent(s) was not changed and carryforward the currently approved consent form.
New Feature: Site Updates tab in the Overall Approval dialog is locked after publishing overall approval.
After the overall / lead site approval is published for a Study-wide Amendment or Continuing Review the ‘Site Updates’ tab will be locked. Any modifications to site-specific approvals can be made individually via the Relying Site Approvals dialog.
New Feature: When posting the lead site/overall approval, sIRBs and Study Managers can indicate whether approved sites had site-specific changes at Continuing Review and for Study-wide Amendments on “Site Updates” tab
A new tab – “Site Updates” – has been added when uploading continuing reviews and study-wide amendments. This new tab captures whether any approved sites had site-specific changes as part of the new approval (e.g., updated or newly stamped consent forms). Any enrolling sites that did not have changes are automatically marked as ‘approved’ and notified when the overall / lead site approval is published. The approval for sites with changes must be uploaded after publishing the lead overall / lead site approval.
New Feature: New question included on ‘Add Continuing Review’ pop-up dialog
A new required question has been added on the ‘Add Continuing Review’ pop-up dialog after the question about whether the continuing review contained a study-wide amendment.
The new question asks:
Did the overall study’s previously approved consent form(s) change (e.g., edits or new IRB stamp)? [Yes/No]
New Feature: A ‘TIN’ bubble displayed on study pages and on the list of search results to indicate if a study is a Trial Innovation Network study
A ‘TIN’ (Trial Innovation Network) bubble appears next to study titles when searching studies and on each study page to indicate which studies are a TIN-supported